Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Gamolenic acid (Eczema)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gamolenic acid 40mg capsules
1305010I0AAAAAA
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | 1,078 |
|
Gamolenic acid 80mg capsules
1305010I0AAABAB
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | 785 |
|
Gamolenic acid 37mg / Vitamin E 10unit capsules
1305010I0AAAPAP
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 67.5mg/5ml oral solution
1305010I0AAAMAM
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 74mg / Vitamin E 10unit capsules
1305010I0AAAQAQ
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 90mg / Vitamin E 15unit capsules
1305010I0AAAIAI
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 95mg / Vitamin E 15unit capsules
1305010I0AAANAN
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.